Adding Cilostazol to Dual Antiplatelet Therapy Achieves Greater Platelet Inhibition than High Maintenance Dose Clopidogrel in Patients With Acute Myocardial Infarction: Results of the Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With AMI (ACCEL-AMI) Study

BACKGROUND—Optimal platelet inhibition is an important therapeutic adjunct in patients acute myocardial infarction (AMI) undergoing coronary stenting. Whether adjunctive cilostazol to dual antiplatelet therapy (triple antiplatelet therapy) can inhibit enhanced platelet reactivity in patients with AM...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation. Cardiovascular interventions 2010-02, Vol.3 (1), p.17-26
Hauptverfasser:	Jeong, Young-Hoon, Hwang, Jin-Yong, Kim, In-Suk, Park, Yongwhi, Hwang, Seok-Jae, Lee, Seung-Whan, Kwak, Choong Hwan, Park, Seong-Wook
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Diphosphate - pharmacology Aged Aspirin - administration & dosage Aspirin - adverse effects Blood Platelets - drug effects Blood Platelets - metabolism Blood Platelets - pathology Blood Vessel Prosthesis Implantation Cells, Cultured Chemotherapy, Adjuvant Drug Therapy, Combination Female Follow-Up Studies Humans Male Middle Aged Myocardial Infarction - physiopathology Myocardial Infarction - therapy Platelet Activation - drug effects Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Prospective Studies Stents - adverse effects Stents - utilization Tetrazoles - administration & dosage Tetrazoles - adverse effects Ticlopidine - administration & dosage Ticlopidine - adverse effects Ticlopidine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!